

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 8.79997048 |
| 2 | * triglyceride catabolic process (GO:0019433) | 8.31540014 |
| 3 | * neutral lipid catabolic process (GO:0046461) | 7.36069861 |
| 4 | * acylglycerol catabolic process (GO:0046464) | 7.36069861 |
| 5 | viral transcription (GO:0019083) | 6.61813996 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 6.53212879 |
| 7 | translational termination (GO:0006415) | 6.34287595 |
| 8 | fatty acid homeostasis (GO:0055089) | 6.33524039 |
| 9 | lipid storage (GO:0019915) | 5.81454811 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.72613808 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 5.63366042 |
| 12 | protein targeting to ER (GO:0045047) | 5.58915734 |
| 13 | transcytosis (GO:0045056) | 5.58378176 |
| 14 | ribosomal small subunit biogenesis (GO:0042274) | 5.57711479 |
| 15 | NADH metabolic process (GO:0006734) | 5.47624374 |
| 16 | * glycerolipid catabolic process (GO:0046503) | 5.35169976 |
| 17 | response to dietary excess (GO:0002021) | 5.34175002 |
| 18 | translational elongation (GO:0006414) | 5.32946888 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.32344685 |
| 20 | regulation of cholesterol storage (GO:0010885) | 5.31916665 |
| 21 | protein localization to endoplasmic reticulum (GO:0070972) | 5.30820194 |
| 22 | peptidyl-threonine dephosphorylation (GO:0035970) | 5.26057705 |
| 23 | protein heterotrimerization (GO:0070208) | 5.24468152 |
| 24 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.23701620 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.22453337 |
| 26 | platelet dense granule organization (GO:0060155) | 5.22216489 |
| 27 | regulation of glycogen (starch) synthase activity (GO:2000465) | 5.15910809 |
| 28 | lipid particle organization (GO:0034389) | 5.07672772 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 5.07512703 |
| 30 | triglyceride biosynthetic process (GO:0019432) | 5.06883648 |
| 31 | DNA deamination (GO:0045006) | 5.06355219 |
| 32 | brown fat cell differentiation (GO:0050873) | 5.04647867 |
| 33 | white fat cell differentiation (GO:0050872) | 5.01597110 |
| 34 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 4.95710657 |
| 35 | biotin metabolic process (GO:0006768) | 4.94270489 |
| 36 | positive regulation of glomerulus development (GO:0090193) | 4.93965293 |
| 37 | lymphoid progenitor cell differentiation (GO:0002320) | 4.91243846 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.90743195 |
| 39 | negative regulation of granulocyte differentiation (GO:0030853) | 4.86848440 |
| 40 | viral life cycle (GO:0019058) | 4.82686689 |
| 41 | negative regulation of metanephros development (GO:0072217) | 4.81610136 |
| 42 | polyol transport (GO:0015791) | 4.81234881 |
| 43 | acylglycerol biosynthetic process (GO:0046463) | 4.80598313 |
| 44 | neutral lipid biosynthetic process (GO:0046460) | 4.80598313 |
| 45 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.78730118 |
| 46 | pattern specification involved in kidney development (GO:0061004) | 4.74892468 |
| 47 | positive regulation of lipid storage (GO:0010884) | 4.70771686 |
| 48 | cellular response to epinephrine stimulus (GO:0071872) | 4.70067646 |
| 49 | cellular protein complex disassembly (GO:0043624) | 4.66024898 |
| 50 | positive regulation of cellular amine metabolic process (GO:0033240) | 4.61676963 |
| 51 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.61624892 |
| 52 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.61571327 |
| 53 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.58793073 |
| 54 | positive regulation of cholesterol efflux (GO:0010875) | 4.56311912 |
| 55 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.54123702 |
| 56 | fatty acid transmembrane transport (GO:1902001) | 4.52371219 |
| 57 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.48561725 |
| 58 | endothelium development (GO:0003158) | 4.47417684 |
| 59 | ethanol oxidation (GO:0006069) | 4.39597713 |
| 60 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.38914562 |
| 61 | nephron tubule formation (GO:0072079) | 4.38780368 |
| 62 | ovulation from ovarian follicle (GO:0001542) | 4.35967953 |
| 63 | respiratory chain complex IV assembly (GO:0008535) | 4.34479453 |
| 64 | negative regulation of macrophage differentiation (GO:0045650) | 4.34359328 |
| 65 | translational initiation (GO:0006413) | 4.32019816 |
| 66 | response to interferon-alpha (GO:0035455) | 4.29195616 |
| 67 | endosome to pigment granule transport (GO:0043485) | 4.27971127 |
| 68 | endosome to melanosome transport (GO:0035646) | 4.27971127 |
| 69 | maturation of SSU-rRNA (GO:0030490) | 4.24535204 |
| 70 | CDP-diacylglycerol metabolic process (GO:0046341) | 4.23354869 |
| 71 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.22602287 |
| 72 | negative regulation of phagocytosis (GO:0050765) | 4.20240618 |
| 73 | * triglyceride metabolic process (GO:0006641) | 4.19248800 |
| 74 | definitive hemopoiesis (GO:0060216) | 4.12986012 |
| 75 | protein complex disassembly (GO:0043241) | 4.07064162 |
| 76 | negative regulation of protein autophosphorylation (GO:0031953) | 4.06890475 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.06610413 |
| 78 | GDP-mannose metabolic process (GO:0019673) | 4.02297431 |
| 79 | response to phenylpropanoid (GO:0080184) | 4.00160060 |
| 80 | response to epinephrine (GO:0071871) | 3.92103656 |
| 81 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.90567043 |
| 82 | positive regulation of cholesterol transport (GO:0032376) | 3.89683056 |
| 83 | positive regulation of sterol transport (GO:0032373) | 3.89683056 |
| 84 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.89561609 |
| 85 | negative regulation of smooth muscle cell migration (GO:0014912) | 3.89084599 |
| 86 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.88572087 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 3.88259976 |
| 88 | * acylglycerol metabolic process (GO:0006639) | 3.87906587 |
| 89 | urogenital system development (GO:0001655) | 3.86638807 |
| 90 | * neutral lipid metabolic process (GO:0006638) | 3.82451878 |
| 91 | macromolecular complex disassembly (GO:0032984) | 3.81314424 |
| 92 | negative regulation of amino acid transport (GO:0051956) | 3.80252478 |
| 93 | alpha-linolenic acid metabolic process (GO:0036109) | 3.77523647 |
| 94 | negative regulation of gluconeogenesis (GO:0045721) | 3.75401737 |
| 95 | positive regulation of hormone metabolic process (GO:0032352) | 3.75330787 |
| 96 | response to interferon-beta (GO:0035456) | 3.74561739 |
| 97 | positive regulation of glycolytic process (GO:0045821) | 3.73328664 |
| 98 | mature B cell differentiation involved in immune response (GO:0002313) | 3.72025372 |
| 99 | protein targeting to membrane (GO:0006612) | 3.71656062 |
| 100 | mesonephros development (GO:0001823) | 3.71153415 |
| 101 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.71024015 |
| 102 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.70018074 |
| 103 | fucose catabolic process (GO:0019317) | 3.69633315 |
| 104 | L-fucose metabolic process (GO:0042354) | 3.69633315 |
| 105 | L-fucose catabolic process (GO:0042355) | 3.69633315 |
| 106 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.68048245 |
| 107 | facial nerve structural organization (GO:0021612) | 3.67725589 |
| 108 | regulation of triglyceride catabolic process (GO:0010896) | 3.62789448 |
| 109 | acyl-CoA biosynthetic process (GO:0071616) | 3.60503664 |
| 110 | thioester biosynthetic process (GO:0035384) | 3.60503664 |
| 111 | glycerol metabolic process (GO:0006071) | 3.60173651 |
| 112 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60092551 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60092551 |
| 114 | regulation of gonadotropin secretion (GO:0032276) | 3.59846083 |
| 115 | regulation of lipid storage (GO:0010883) | 3.58276957 |
| 116 | positive regulation of metanephros development (GO:0072216) | 3.57234686 |
| 117 | ribosomal large subunit biogenesis (GO:0042273) | 3.57143088 |
| 118 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.56585186 |
| 119 | primary alcohol metabolic process (GO:0034308) | 3.56217862 |
| 120 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 3.55847982 |
| 121 | positive regulation of glucose import (GO:0046326) | 3.54759872 |
| 122 | mannosylation (GO:0097502) | 3.54334104 |
| 123 | valine metabolic process (GO:0006573) | 3.52956265 |
| 124 | N-acetylneuraminate metabolic process (GO:0006054) | 3.52738074 |
| 125 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.52186368 |
| 126 | tricarboxylic acid metabolic process (GO:0072350) | 3.51450107 |
| 127 | phosphatidic acid metabolic process (GO:0046473) | 3.51274261 |
| 128 | phosphatidic acid biosynthetic process (GO:0006654) | 3.51274261 |
| 129 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.48771687 |
| 130 | cGMP-mediated signaling (GO:0019934) | 3.46033385 |
| 131 | retinol metabolic process (GO:0042572) | 3.45582708 |
| 132 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.42641779 |
| 133 | regulation of receptor binding (GO:1900120) | 3.41983281 |
| 134 | cellular response to lithium ion (GO:0071285) | 3.38258395 |
| 135 | generation of neurons (GO:0048699) | 3.37536182 |
| 136 | triglyceride homeostasis (GO:0070328) | 3.34935021 |
| 137 | acylglycerol homeostasis (GO:0055090) | 3.34935021 |
| 138 | negative regulation of lipid catabolic process (GO:0050995) | 3.33014065 |
| 139 | carnitine shuttle (GO:0006853) | 3.32791927 |
| 140 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.32641593 |
| 141 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.32476283 |
| 142 | protein localization to cell surface (GO:0034394) | 3.32414739 |
| 143 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.31437816 |
| 144 | glomerular filtration (GO:0003094) | 3.31245928 |
| 145 | ethanol metabolic process (GO:0006067) | 3.30568004 |
| 146 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.30565837 |
| 147 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.29843019 |
| 148 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.29283836 |
| 149 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.28141911 |
| 150 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.27477752 |
| 151 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.26603307 |
| 152 | positive regulation of protein export from nucleus (GO:0046827) | 3.25979812 |
| 153 | cytochrome complex assembly (GO:0017004) | 3.23745471 |
| 154 | translation (GO:0006412) | 3.23187441 |
| 155 | amino sugar catabolic process (GO:0046348) | 3.21057414 |
| 156 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.19901643 |
| 157 | mRNA catabolic process (GO:0006402) | 3.16343817 |
| 158 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.16063479 |
| 159 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.16063479 |
| 160 | * diacylglycerol metabolic process (GO:0046339) | 3.15428690 |
| 161 | thyroid gland development (GO:0030878) | 3.14659607 |
| 162 | regulation of protein kinase A signaling (GO:0010738) | 3.14259623 |
| 163 | negative regulation of lipid storage (GO:0010888) | 3.13093114 |
| 164 | regulation of lipid catabolic process (GO:0050994) | 3.12806378 |
| 165 | metanephric nephron tubule development (GO:0072234) | 3.12791729 |
| 166 | metanephric tubule development (GO:0072170) | 3.12791729 |
| 167 | GPI anchor biosynthetic process (GO:0006506) | 3.12552257 |
| 168 | L-serine transport (GO:0015825) | 3.12149895 |
| 169 | positive regulation of B cell differentiation (GO:0045579) | 3.12094001 |
| 170 | telomere maintenance via recombination (GO:0000722) | 3.11408739 |
| 171 | alditol metabolic process (GO:0019400) | 3.10432954 |
| 172 | fatty acid beta-oxidation (GO:0006635) | 3.08723667 |
| 173 | secretory granule organization (GO:0033363) | 3.06047784 |
| 174 | megakaryocyte development (GO:0035855) | 3.04129780 |
| 175 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02948623 |
| 176 | mesenchymal to epithelial transition (GO:0060231) | 3.01748031 |
| 177 | nephron epithelium development (GO:0072009) | 3.00397854 |
| 178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98450898 |
| 179 | phospholipid scrambling (GO:0017121) | 2.95831887 |
| 180 | lymph node development (GO:0048535) | 2.95709673 |
| 181 | regulation of hormone metabolic process (GO:0032350) | 2.95424096 |
| 182 | DNA replication initiation (GO:0006270) | 2.95209843 |
| 183 | RNA catabolic process (GO:0006401) | 2.94443053 |
| 184 | mature B cell differentiation (GO:0002335) | 2.94396407 |
| 185 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92210332 |
| 186 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.91838406 |
| 187 | C-terminal protein lipidation (GO:0006501) | 2.91162699 |
| 188 | genitalia morphogenesis (GO:0035112) | 2.90939602 |
| 189 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.88541008 |
| 190 | pseudouridine synthesis (GO:0001522) | 2.87827561 |
| 191 | response to folic acid (GO:0051593) | 2.86568194 |
| 192 | cranial nerve morphogenesis (GO:0021602) | 2.82093756 |
| 193 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.81477232 |
| 194 | termination of RNA polymerase III transcription (GO:0006386) | 2.81477232 |
| 195 | DNA strand elongation (GO:0022616) | 2.80506294 |
| 196 | postsynaptic membrane organization (GO:0001941) | 2.79202329 |
| 197 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.78520371 |
| 198 | low-density lipoprotein particle clearance (GO:0034383) | 11.5969472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.97117255 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.61012239 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.01001584 |
| 4 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.49511780 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47670102 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.47524760 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.40176590 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.25557105 |
| 9 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.19694709 |
| 10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.18990789 |
| 11 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.11371676 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09855270 |
| 13 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 3.05216236 |
| 14 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.95845605 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.94976342 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94024881 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.88902079 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.86724124 |
| 19 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.84783731 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.58875864 |
| 21 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.57843587 |
| 22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.56431714 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51169239 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.49821518 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48308096 |
| 26 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.46728989 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41843622 |
| 28 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38718150 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36472135 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.34280942 |
| 31 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26618907 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.25892030 |
| 33 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25093434 |
| 34 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24191360 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.21793131 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18755245 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.15059316 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.14890768 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.13696244 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.13395867 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.11572625 |
| 42 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11418023 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.08995108 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07182201 |
| 45 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.06342754 |
| 46 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.3782185 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.99180996 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95870302 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.93422403 |
| 50 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.92703742 |
| 51 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.91173161 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.90679568 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88908534 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.86989379 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81949773 |
| 56 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.81120839 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.80289599 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.79410987 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79002358 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.78636005 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.77399154 |
| 62 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.76747699 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74619343 |
| 64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74619343 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72607081 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71864957 |
| 67 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69531051 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68098877 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.62726166 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.62110498 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60908799 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.60210717 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59836788 |
| 74 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58460268 |
| 75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57852410 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.56718111 |
| 77 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56302347 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54183812 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52939272 |
| 80 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.51767025 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48708658 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46434941 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46205233 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42023003 |
| 85 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41571253 |
| 86 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40112766 |
| 87 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40112766 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.38474048 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38337922 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36207867 |
| 91 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35136684 |
| 92 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35012679 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33588041 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.32696478 |
| 95 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32405635 |
| 96 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31384330 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.30696207 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28173595 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27340795 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.27147017 |
| 101 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26796503 |
| 102 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26326548 |
| 103 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25801049 |
| 104 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.25632993 |
| 105 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.25486811 |
| 106 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.24955212 |
| 107 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24287804 |
| 108 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.22525993 |
| 109 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21882975 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.21683186 |
| 111 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21506549 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20136167 |
| 113 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19894554 |
| 114 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19128470 |
| 115 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.18434868 |
| 116 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17834892 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16598535 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16245238 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16175931 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15307769 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13803760 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13017832 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11651713 |
| 124 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.11647782 |
| 125 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.11112493 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10959786 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10463891 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10368547 |
| 129 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09960050 |
| 130 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09091132 |
| 131 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07070479 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05639001 |
| 133 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05379403 |
| 134 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.04322770 |
| 135 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.03493600 |
| 136 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03141571 |
| 137 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02834127 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02641159 |
| 139 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02399072 |
| 140 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02321057 |
| 141 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.01942653 |
| 142 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01899962 |
| 143 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00475570 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99898622 |
| 145 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98672450 |
| 146 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.98630859 |
| 147 | P68_20966046_ChIP-Seq_HELA_Human | 0.98353598 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98076610 |
| 149 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97991381 |
| 150 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97824352 |
| 151 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97654706 |
| 152 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97532627 |
| 153 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97462311 |
| 154 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97378846 |
| 155 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97321686 |
| 156 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97145759 |
| 157 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95551574 |
| 158 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95020695 |
| 159 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94875340 |
| 160 | SPI1_23127762_ChIP-Seq_K562_Human | 0.94449462 |
| 161 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93245691 |
| 162 | MAF_26560356_Chip-Seq_TH2_Human | 0.91864687 |
| 163 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91575032 |
| 164 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.90460491 |
| 165 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90129361 |
| 166 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.88844716 |
| 167 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88551489 |
| 168 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88151751 |
| 169 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88143744 |
| 170 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87954973 |
| 171 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87443560 |
| 172 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87248687 |
| 173 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86626216 |
| 174 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86287256 |
| 175 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86142486 |
| 176 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86084270 |
| 177 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85830218 |
| 178 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84098877 |
| 179 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83849935 |
| 180 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.83606918 |
| 181 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82940796 |
| 182 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82045597 |
| 183 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81695994 |
| 184 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.81207395 |
| 185 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81048988 |
| 186 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80790161 |
| 187 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.79973258 |
| 188 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.79874632 |
| 189 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.78931811 |
| 190 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78286085 |
| 191 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77192636 |
| 192 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75066889 |
| 193 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.74783907 |
| 194 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.74618296 |
| 195 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.74285007 |
| 196 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74146847 |
| 197 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72390940 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 9.22877637 |
| 2 | MP0009379_abnormal_foot_pigmentation | 6.80242630 |
| 3 | * MP0005666_abnormal_adipose_tissue | 5.41164432 |
| 4 | MP0004185_abnormal_adipocyte_glucose | 4.26706299 |
| 5 | * MP0002971_abnormal_brown_adipose | 4.12980476 |
| 6 | * MP0004130_abnormal_muscle_cell | 4.07502572 |
| 7 | * MP0005375_adipose_tissue_phenotype | 4.05347955 |
| 8 | MP0003724_increased_susceptibility_to | 3.96611257 |
| 9 | MP0005174_abnormal_tail_pigmentation | 3.78797544 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.68048281 |
| 11 | MP0001188_hyperpigmentation | 3.23895773 |
| 12 | MP0005409_darkened_coat_color | 3.07183547 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.95641828 |
| 14 | MP0004147_increased_porphyrin_level | 2.84866376 |
| 15 | * MP0009115_abnormal_fat_cell | 2.80586984 |
| 16 | MP0005075_abnormal_melanosome_morpholog | 2.71436932 |
| 17 | MP0001545_abnormal_hematopoietic_system | 2.59857695 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.59857695 |
| 19 | MP0006138_congestive_heart_failure | 2.58478370 |
| 20 | MP0000003_abnormal_adipose_tissue | 2.55391363 |
| 21 | * MP0002970_abnormal_white_adipose | 2.54953157 |
| 22 | MP0005535_abnormal_body_temperature | 2.54879796 |
| 23 | MP0000490_abnormal_crypts_of | 2.51022357 |
| 24 | MP0001986_abnormal_taste_sensitivity | 2.46552205 |
| 25 | MP0000685_abnormal_immune_system | 2.44214706 |
| 26 | MP0001835_abnormal_antigen_presentation | 2.41708355 |
| 27 | MP0009785_altered_susceptibility_to | 2.40567304 |
| 28 | MP0002095_abnormal_skin_pigmentation | 2.40453810 |
| 29 | * MP0005334_abnormal_fat_pad | 2.37436817 |
| 30 | MP0006292_abnormal_olfactory_placode | 2.35984439 |
| 31 | MP0000015_abnormal_ear_pigmentation | 2.29276919 |
| 32 | MP0003011_delayed_dark_adaptation | 2.23199090 |
| 33 | MP0000681_abnormal_thyroid_gland | 2.20951013 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 2.20175323 |
| 35 | MP0005671_abnormal_response_to | 2.18833269 |
| 36 | MP0005275_abnormal_skin_tensile | 2.14518851 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 2.11623592 |
| 38 | MP0003303_peritoneal_inflammation | 2.08004997 |
| 39 | MP0003879_abnormal_hair_cell | 2.07637117 |
| 40 | * MP0003959_abnormal_lean_body | 2.02668855 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 2.00606146 |
| 42 | MP0000751_myopathy | 1.98849120 |
| 43 | MP0003690_abnormal_glial_cell | 1.97648989 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.91053649 |
| 45 | * MP0002118_abnormal_lipid_homeostasis | 1.89628418 |
| 46 | MP0003828_pulmonary_edema | 1.85304746 |
| 47 | MP0005025_abnormal_response_to | 1.79800862 |
| 48 | MP0003646_muscle_fatigue | 1.75161899 |
| 49 | * MP0005448_abnormal_energy_balance | 1.72902507 |
| 50 | MP0000372_irregular_coat_pigmentation | 1.72849974 |
| 51 | MP0003436_decreased_susceptibility_to | 1.71632151 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.70059454 |
| 53 | MP0002398_abnormal_bone_marrow | 1.68594465 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.67529559 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.57805262 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.56870807 |
| 57 | * MP0005452_abnormal_adipose_tissue | 1.56439850 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.56390338 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.56353169 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.54105196 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.52930095 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.50617224 |
| 63 | MP0002723_abnormal_immune_serum | 1.47536174 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.47452845 |
| 65 | MP0001800_abnormal_humoral_immune | 1.46923493 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.46452322 |
| 67 | MP0001873_stomach_inflammation | 1.46142996 |
| 68 | MP0001819_abnormal_immune_cell | 1.43380765 |
| 69 | MP0001661_extended_life_span | 1.41753351 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.40792115 |
| 71 | MP0003136_yellow_coat_color | 1.39216409 |
| 72 | MP0003191_abnormal_cellular_cholesterol | 1.38610023 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.38519855 |
| 74 | MP0002722_abnormal_immune_system | 1.37772805 |
| 75 | MP0005385_cardiovascular_system_phenoty | 1.36859268 |
| 76 | MP0001544_abnormal_cardiovascular_syste | 1.36859268 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.35895990 |
| 78 | MP0002108_abnormal_muscle_morphology | 1.35786199 |
| 79 | MP0000716_abnormal_immune_system | 1.35607395 |
| 80 | MP0003866_abnormal_defecation | 1.33920327 |
| 81 | MP0002452_abnormal_antigen_presenting | 1.33819737 |
| 82 | MP0002429_abnormal_blood_cell | 1.28644119 |
| 83 | MP0002177_abnormal_outer_ear | 1.27976819 |
| 84 | MP0004272_abnormal_basement_membrane | 1.27625639 |
| 85 | * MP0002078_abnormal_glucose_homeostasis | 1.26697045 |
| 86 | MP0002876_abnormal_thyroid_physiology | 1.26367601 |
| 87 | MP0003950_abnormal_plasma_membrane | 1.25829765 |
| 88 | MP0003693_abnormal_embryo_hatching | 1.25350033 |
| 89 | MP0003279_aneurysm | 1.25120479 |
| 90 | MP0002933_joint_inflammation | 1.23413505 |
| 91 | MP0004381_abnormal_hair_follicle | 1.22662089 |
| 92 | MP0002166_altered_tumor_susceptibility | 1.22625666 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 1.22074092 |
| 94 | MP0006054_spinal_hemorrhage | 1.21174186 |
| 95 | MP0002419_abnormal_innate_immunity | 1.19964631 |
| 96 | MP0009780_abnormal_chondrocyte_physiolo | 1.16642523 |
| 97 | MP0005647_abnormal_sex_gland | 1.15575519 |
| 98 | MP0001853_heart_inflammation | 1.14375980 |
| 99 | MP0000049_abnormal_middle_ear | 1.09834106 |
| 100 | MP0001663_abnormal_digestive_system | 1.05631692 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 1.05575213 |
| 102 | MP0000249_abnormal_blood_vessel | 1.04810522 |
| 103 | MP0000759_abnormal_skeletal_muscle | 1.03160779 |
| 104 | MP0002132_abnormal_respiratory_system | 1.03092061 |
| 105 | MP0004087_abnormal_muscle_fiber | 1.02874810 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.99656299 |
| 107 | MP0008469_abnormal_protein_level | 0.98565908 |
| 108 | MP0001501_abnormal_sleep_pattern | 0.98257197 |
| 109 | * MP0003948_abnormal_gas_homeostasis | 0.94125187 |
| 110 | MP0008058_abnormal_DNA_repair | 0.94007307 |
| 111 | MP0005164_abnormal_response_to | 0.93853562 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.93473576 |
| 113 | MP0002102_abnormal_ear_morphology | 0.93317839 |
| 114 | MP0001764_abnormal_homeostasis | 0.92315480 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.90317889 |
| 116 | MP0005387_immune_system_phenotype | 0.89573504 |
| 117 | MP0001790_abnormal_immune_system | 0.89573504 |
| 118 | MP0001881_abnormal_mammary_gland | 0.89299273 |
| 119 | MP0000703_abnormal_thymus_morphology | 0.89013118 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.88728443 |
| 121 | MP0002006_tumorigenesis | 0.88658439 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.87283190 |
| 123 | MP0003938_abnormal_ear_development | 0.86211227 |
| 124 | * MP0000609_abnormal_liver_physiology | 0.84110822 |
| 125 | MP0001958_emphysema | 0.83719904 |
| 126 | MP0002938_white_spotting | 0.82649065 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.82361354 |
| 128 | MP0003786_premature_aging | 0.81277543 |
| 129 | MP0002075_abnormal_coat/hair_pigmentati | 0.79957589 |
| 130 | MP0005365_abnormal_bile_salt | 0.78922395 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.78777087 |
| 132 | MP0008775_abnormal_heart_ventricle | 0.77728166 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.77012317 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.75869911 |
| 135 | * MP0003953_abnormal_hormone_level | 0.75582957 |
| 136 | MP0005084_abnormal_gallbladder_morpholo | 0.75170560 |
| 137 | MP0004084_abnormal_cardiac_muscle | 0.75156784 |
| 138 | MP0000477_abnormal_intestine_morphology | 0.74849769 |
| 139 | MP0005620_abnormal_muscle_contractility | 0.74681649 |
| 140 | MP0002972_abnormal_cardiac_muscle | 0.73713521 |
| 141 | MP0002405_respiratory_system_inflammati | 0.73524128 |
| 142 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.72641063 |
| 143 | MP0008569_lethality_at_weaning | 0.72059151 |
| 144 | MP0000749_muscle_degeneration | 0.70495725 |
| 145 | MP0010368_abnormal_lymphatic_system | 0.69698057 |
| 146 | MP0000858_altered_metastatic_potential | 0.69307475 |
| 147 | MP0002133_abnormal_respiratory_system | 0.68995972 |
| 148 | MP0005388_respiratory_system_phenotype | 0.68995972 |
| 149 | MP0010094_abnormal_chromosome_stability | 0.68849731 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.68428397 |
| 151 | MP0001879_abnormal_lymphatic_vessel | 0.67055594 |
| 152 | MP0003186_abnormal_redox_activity | 0.65556102 |
| 153 | MP0003075_altered_response_to | 0.65403798 |
| 154 | MP0000230_abnormal_systemic_arterial | 0.64294807 |
| 155 | MP0004036_abnormal_muscle_relaxation | 0.63485309 |
| 156 | MP0004957_abnormal_blastocyst_morpholog | 0.62600279 |
| 157 | MP0005379_endocrine/exocrine_gland_phen | 0.62186091 |
| 158 | MP0005636_abnormal_mineral_homeostasis | 0.61858843 |
| 159 | MP0000343_altered_response_to | 0.61613921 |
| 160 | MP0002796_impaired_skin_barrier | 0.61289693 |
| 161 | MP0004142_abnormal_muscle_tone | 0.60702436 |
| 162 | MP0001348_abnormal_lacrimal_gland | 0.60177279 |
| 163 | MP0009643_abnormal_urine_homeostasis | 0.59692865 |
| 164 | MP0003566_abnormal_cell_adhesion | 0.59649624 |
| 165 | MP0010630_abnormal_cardiac_muscle | 0.57886620 |
| 166 | MP0002638_abnormal_pupillary_reflex | 0.57830860 |
| 167 | MP0008260_abnormal_autophagy | 0.57215289 |
| 168 | MP0005381_digestive/alimentary_phenotyp | 0.55828207 |
| 169 | MP0001177_atelectasis | 0.55344637 |
| 170 | MP0000470_abnormal_stomach_morphology | 0.54689895 |
| 171 | MP0003943_abnormal_hepatobiliary_system | 0.52667010 |
| 172 | MP0005508_abnormal_skeleton_morphology | 0.51319209 |
| 173 | MP0000613_abnormal_salivary_gland | 0.51057291 |
| 174 | MP0000313_abnormal_cell_death | 0.50738224 |
| 175 | MP0003137_abnormal_impulse_conducting | 0.50647573 |
| 176 | MP0004858_abnormal_nervous_system | 0.49903378 |
| 177 | MP0005369_muscle_phenotype | 0.48557575 |
| 178 | MP0003091_abnormal_cell_migration | 0.47728019 |
| 179 | MP0009672_abnormal_birth_weight | 0.47294454 |
| 180 | MP0003448_altered_tumor_morphology | 0.45690606 |
| 181 | MP0005165_increased_susceptibility_to | 0.44962509 |
| 182 | MP0001614_abnormal_blood_vessel | 0.44805514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oligomenorrhea (HP:0000876) | 8.63662082 |
| 2 | Hypertriglyceridemia (HP:0002155) | 7.57192312 |
| 3 | Acanthosis nigricans (HP:0000956) | 7.54673754 |
| 4 | Reduced antithrombin III activity (HP:0001976) | 7.13155283 |
| 5 | Hypothermia (HP:0002045) | 6.51696529 |
| 6 | Type I transferrin isoform profile (HP:0003642) | 6.43761054 |
| 7 | Thyroid-stimulating hormone excess (HP:0002925) | 6.00788288 |
| 8 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.27261505 |
| 9 | Abnormal number of erythroid precursors (HP:0012131) | 5.20323178 |
| 10 | Increased variability in muscle fiber diameter (HP:0003557) | 5.19704482 |
| 11 | Difficulty running (HP:0009046) | 4.76262831 |
| 12 | Abnormal protein glycosylation (HP:0012346) | 4.68972816 |
| 13 | Abnormal glycosylation (HP:0012345) | 4.68972816 |
| 14 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.68972816 |
| 15 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.68972816 |
| 16 | Protrusio acetabuli (HP:0003179) | 4.63239230 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.33060634 |
| 18 | Aplastic anemia (HP:0001915) | 4.18213823 |
| 19 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.17351731 |
| 20 | Reticulocytopenia (HP:0001896) | 4.14180125 |
| 21 | Hyperlipoproteinemia (HP:0010980) | 4.05167467 |
| 22 | Thrombocytosis (HP:0001894) | 3.97399895 |
| 23 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.96555034 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.84423630 |
| 25 | Myocardial infarction (HP:0001658) | 3.80769929 |
| 26 | Hemorrhage of the eye (HP:0011885) | 3.73177471 |
| 27 | Abnormal eating behavior (HP:0100738) | 3.70241543 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.64305249 |
| 29 | Severe visual impairment (HP:0001141) | 3.63247128 |
| 30 | Bone cyst (HP:0012062) | 3.62684352 |
| 31 | Growth hormone excess (HP:0000845) | 3.59942206 |
| 32 | Pigmentary retinal degeneration (HP:0001146) | 3.47361874 |
| 33 | Muscle fiber splitting (HP:0003555) | 3.46150816 |
| 34 | Pallor (HP:0000980) | 3.41953311 |
| 35 | Long foot (HP:0001833) | 3.41251311 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.35647635 |
| 37 | Skin nodule (HP:0200036) | 3.35416657 |
| 38 | Spinal rigidity (HP:0003306) | 3.34999434 |
| 39 | Macrocytic anemia (HP:0001972) | 3.28539068 |
| 40 | Epidermoid cyst (HP:0200040) | 3.27433507 |
| 41 | Increased connective tissue (HP:0009025) | 3.26323328 |
| 42 | Hypercortisolism (HP:0001578) | 3.25723642 |
| 43 | Hepatocellular necrosis (HP:0001404) | 3.23444057 |
| 44 | Nonprogressive disorder (HP:0003680) | 3.22226710 |
| 45 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.20891367 |
| 46 | Chronic otitis media (HP:0000389) | 3.19574688 |
| 47 | Axonal loss (HP:0003447) | 3.12776835 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 3.10996074 |
| 49 | Nausea (HP:0002018) | 3.05157418 |
| 50 | Prolonged bleeding time (HP:0003010) | 3.04761108 |
| 51 | Petechiae (HP:0000967) | 3.03803246 |
| 52 | Muscle fiber atrophy (HP:0100295) | 3.01443564 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 2.98994137 |
| 54 | Type 2 muscle fiber atrophy (HP:0003554) | 2.97237169 |
| 55 | Microvesicular hepatic steatosis (HP:0001414) | 2.96456346 |
| 56 | Complement deficiency (HP:0004431) | 2.96110836 |
| 57 | Back pain (HP:0003418) | 2.96016927 |
| 58 | Subcapsular cataract (HP:0000523) | 2.93660258 |
| 59 | Polycythemia (HP:0001901) | 2.91913381 |
| 60 | Ectopia lentis (HP:0001083) | 2.91823620 |
| 61 | * Insulin resistance (HP:0000855) | 2.91000753 |
| 62 | IgM deficiency (HP:0002850) | 2.86674343 |
| 63 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.86352727 |
| 64 | Exertional dyspnea (HP:0002875) | 2.86244554 |
| 65 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.85750821 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.85750821 |
| 67 | Polyphagia (HP:0002591) | 2.83079817 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.79481223 |
| 69 | Ankle contracture (HP:0006466) | 2.78907422 |
| 70 | Lipid accumulation in hepatocytes (HP:0006561) | 2.77654355 |
| 71 | Myositis (HP:0100614) | 2.74739828 |
| 72 | Flat occiput (HP:0005469) | 2.73948219 |
| 73 | Colitis (HP:0002583) | 2.73879685 |
| 74 | Cortical visual impairment (HP:0100704) | 2.73834388 |
| 75 | Aortic aneurysm (HP:0004942) | 2.72569508 |
| 76 | Xanthomatosis (HP:0000991) | 2.72403350 |
| 77 | Prominent supraorbital ridges (HP:0000336) | 2.71415057 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70964757 |
| 79 | Hepatic necrosis (HP:0002605) | 2.70597286 |
| 80 | Increased intramyocellular lipid droplets (HP:0012240) | 2.68534356 |
| 81 | Acute lymphatic leukemia (HP:0006721) | 2.67196171 |
| 82 | Ileus (HP:0002595) | 2.66642086 |
| 83 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.66339702 |
| 84 | Renal Fanconi syndrome (HP:0001994) | 2.65619814 |
| 85 | Lymphangioma (HP:0100764) | 2.64079325 |
| 86 | Cerebral aneurysm (HP:0004944) | 2.63892967 |
| 87 | Abnormality of complement system (HP:0005339) | 2.60221303 |
| 88 | Microcytic anemia (HP:0001935) | 2.58917886 |
| 89 | Polar cataract (HP:0010696) | 2.56897158 |
| 90 | Neck muscle weakness (HP:0000467) | 2.56678964 |
| 91 | Increased muscle lipid content (HP:0009058) | 2.54880404 |
| 92 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.54769847 |
| 93 | Accelerated skeletal maturation (HP:0005616) | 2.52944296 |
| 94 | Easy fatigability (HP:0003388) | 2.52273592 |
| 95 | Rhabdomyolysis (HP:0003201) | 2.52255828 |
| 96 | Striae distensae (HP:0001065) | 2.52191882 |
| 97 | Frequent falls (HP:0002359) | 2.51960979 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.48269879 |
| 99 | Lipoatrophy (HP:0100578) | 2.46103568 |
| 100 | Epistaxis (HP:0000421) | 2.44640386 |
| 101 | Abnormal hemoglobin (HP:0011902) | 2.44256462 |
| 102 | Infantile muscular hypotonia (HP:0008947) | 2.41227628 |
| 103 | Attenuation of retinal blood vessels (HP:0007843) | 2.40914965 |
| 104 | Shallow orbits (HP:0000586) | 2.39045300 |
| 105 | Lower limb hyperreflexia (HP:0002395) | 2.38007510 |
| 106 | Abnormal platelet function (HP:0011869) | 2.32821490 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.32821490 |
| 108 | Increased serum pyruvate (HP:0003542) | 2.31818226 |
| 109 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30125453 |
| 110 | Pancytopenia (HP:0001876) | 2.27781128 |
| 111 | Progressive muscle weakness (HP:0003323) | 2.26226740 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.26095741 |
| 113 | Amyloidosis (HP:0011034) | 2.26016076 |
| 114 | Cervical subluxation (HP:0003308) | 2.24481708 |
| 115 | Gowers sign (HP:0003391) | 2.22184650 |
| 116 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20640169 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 2.19003816 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 2.18928511 |
| 119 | Respiratory difficulties (HP:0002880) | 2.18323864 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 2.15767100 |
| 121 | Hypoproteinemia (HP:0003075) | 2.14672011 |
| 122 | Abnormality of the periventricular white matter (HP:0002518) | 2.13044974 |
| 123 | Stridor (HP:0010307) | 2.11285350 |
| 124 | Acute myeloid leukemia (HP:0004808) | 2.09467960 |
| 125 | Abnormality of glycolysis (HP:0004366) | 2.09379800 |
| 126 | Vertebral compression fractures (HP:0002953) | 2.07572118 |
| 127 | Broad metatarsal (HP:0001783) | 2.06454979 |
| 128 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04591032 |
| 129 | Hyperpituitarism (HP:0010514) | 2.04240701 |
| 130 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.01821635 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 2.01413336 |
| 132 | Biconcave vertebral bodies (HP:0004586) | 2.00775031 |
| 133 | Myoglobinuria (HP:0002913) | 1.97837285 |
| 134 | Wormian bones (HP:0002645) | 1.97652025 |
| 135 | Mitochondrial inheritance (HP:0001427) | 1.97401576 |
| 136 | Thoracic kyphosis (HP:0002942) | 1.97199895 |
| 137 | Premature rupture of membranes (HP:0001788) | 1.96919677 |
| 138 | Large hands (HP:0001176) | 1.96130910 |
| 139 | Abnormality of B cell number (HP:0010975) | 1.94115730 |
| 140 | B lymphocytopenia (HP:0010976) | 1.94115730 |
| 141 | Entropion (HP:0000621) | 1.94051778 |
| 142 | Recurrent bronchitis (HP:0002837) | 1.94051102 |
| 143 | Abnormality of the columella (HP:0009929) | 1.94041494 |
| 144 | Agammaglobulinemia (HP:0004432) | 1.93707014 |
| 145 | Pulmonary artery stenosis (HP:0004415) | 1.92038496 |
| 146 | Increased serum lactate (HP:0002151) | 1.91965619 |
| 147 | Purpura (HP:0000979) | 1.91680493 |
| 148 | Glucose intolerance (HP:0000833) | 1.91580445 |
| 149 | Hyperbilirubinemia (HP:0002904) | 1.90968263 |
| 150 | Dilatation of the ascending aorta (HP:0005111) | 1.90542700 |
| 151 | Erythema (HP:0010783) | 1.90034589 |
| 152 | Gastrointestinal dysmotility (HP:0002579) | 1.89896643 |
| 153 | Hypoalphalipoproteinemia (HP:0003233) | 1.89126772 |
| 154 | Myotonia (HP:0002486) | 1.88091175 |
| 155 | Atrioventricular block (HP:0001678) | 1.87278778 |
| 156 | Muscle stiffness (HP:0003552) | 1.86801385 |
| 157 | Migraine (HP:0002076) | 1.86114965 |
| 158 | Obstructive sleep apnea (HP:0002870) | 1.84896969 |
| 159 | Hyporeflexia of lower limbs (HP:0002600) | 1.83510568 |
| 160 | Vascular tortuosity (HP:0004948) | 1.83280791 |
| 161 | Mitral valve prolapse (HP:0001634) | 1.83276609 |
| 162 | Esophageal varix (HP:0002040) | 1.82758490 |
| 163 | Broad face (HP:0000283) | 1.82654964 |
| 164 | Hyperalaninemia (HP:0003348) | 1.82544367 |
| 165 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.82544367 |
| 166 | Abnormality of alanine metabolism (HP:0010916) | 1.82544367 |
| 167 | Bradycardia (HP:0001662) | 1.81727695 |
| 168 | Potter facies (HP:0002009) | 1.79074572 |
| 169 | Facial shape deformation (HP:0011334) | 1.79074572 |
| 170 | Megalocornea (HP:0000485) | 1.78905973 |
| 171 | Amaurosis fugax (HP:0100576) | 1.78870041 |
| 172 | Pendular nystagmus (HP:0012043) | 1.78075622 |
| 173 | Venous abnormality (HP:0002624) | 1.77466625 |
| 174 | Nuclear cataract (HP:0100018) | 1.77004016 |
| 175 | Mutism (HP:0002300) | 1.74551711 |
| 176 | Meningitis (HP:0001287) | 1.74427163 |
| 177 | Impulsivity (HP:0100710) | 1.73833831 |
| 178 | Congenital, generalized hypertrichosis (HP:0004540) | 1.73714478 |
| 179 | Dry hair (HP:0011359) | 1.73146813 |
| 180 | Beaking of vertebral bodies (HP:0004568) | 1.73024899 |
| 181 | Hypoplasia of the iris (HP:0007676) | 1.72984702 |
| 182 | Nasal polyposis (HP:0100582) | 1.72378220 |
| 183 | Abnormality of the lower motor neuron (HP:0002366) | 1.71669734 |
| 184 | Foot dorsiflexor weakness (HP:0009027) | 1.70751331 |
| 185 | Recurrent abscess formation (HP:0002722) | 1.70649556 |
| 186 | Increased CSF lactate (HP:0002490) | 1.70367022 |
| 187 | True hermaphroditism (HP:0010459) | 1.69565400 |
| 188 | Exercise-induced myalgia (HP:0003738) | 1.69416056 |
| 189 | Type II lissencephaly (HP:0007260) | 1.68365863 |
| 190 | Gastrointestinal stroma tumor (HP:0100723) | 1.65894077 |
| 191 | Abnormal spermatogenesis (HP:0008669) | 1.63455705 |
| 192 | Albinism (HP:0001022) | 1.63246752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 9.89753519 |
| 2 | TRIB3 | 4.31273727 |
| 3 | NLK | 3.80721652 |
| 4 | RIPK1 | 3.50160596 |
| 5 | EPHB2 | 3.50143138 |
| 6 | DDR2 | 3.12836608 |
| 7 | KIT | 3.09792242 |
| 8 | NME2 | 3.04693281 |
| 9 | SIK1 | 3.02603902 |
| 10 | TESK1 | 2.97533190 |
| 11 | STK16 | 2.97295338 |
| 12 | FES | 2.86085390 |
| 13 | FLT3 | 2.65506785 |
| 14 | ERN1 | 2.55029368 |
| 15 | MUSK | 2.49179523 |
| 16 | TEC | 2.23724290 |
| 17 | CDK19 | 2.22577011 |
| 18 | PIM2 | 2.17404527 |
| 19 | WEE1 | 2.14266759 |
| 20 | EIF2AK3 | 2.13611902 |
| 21 | LATS2 | 2.10554920 |
| 22 | MKNK2 | 2.09648623 |
| 23 | CAMK1D | 1.94701794 |
| 24 | CAMKK2 | 1.79556544 |
| 25 | * PRKAA2 | 1.72434608 |
| 26 | ABL2 | 1.69822822 |
| 27 | GRK5 | 1.65483259 |
| 28 | TLK1 | 1.63330390 |
| 29 | PDGFRA | 1.63017958 |
| 30 | MKNK1 | 1.57528650 |
| 31 | CDK6 | 1.50785225 |
| 32 | CSF1R | 1.39217981 |
| 33 | PDPK1 | 1.38125250 |
| 34 | ARAF | 1.37586911 |
| 35 | MAP3K13 | 1.33459406 |
| 36 | BTK | 1.30926162 |
| 37 | TGFBR1 | 1.30843210 |
| 38 | MATK | 1.27279905 |
| 39 | TIE1 | 1.20646894 |
| 40 | TGFBR2 | 1.20495909 |
| 41 | DYRK3 | 1.19538205 |
| 42 | CAMK1G | 1.18081909 |
| 43 | EPHB1 | 1.16934505 |
| 44 | BRSK2 | 1.15510940 |
| 45 | MAP2K7 | 1.14671395 |
| 46 | EPHA3 | 1.13699310 |
| 47 | MAP2K1 | 1.11633632 |
| 48 | LATS1 | 1.10992579 |
| 49 | VRK1 | 1.07487697 |
| 50 | TRPM7 | 1.07048114 |
| 51 | MAP3K12 | 1.06897343 |
| 52 | PRPF4B | 1.06610931 |
| 53 | EIF2AK1 | 1.06215493 |
| 54 | ACVR1B | 1.05227616 |
| 55 | PKN2 | 1.04583778 |
| 56 | BCKDK | 0.98600244 |
| 57 | NEK9 | 0.97845800 |
| 58 | MOS | 0.96958902 |
| 59 | BLK | 0.94379676 |
| 60 | EIF2AK2 | 0.93848778 |
| 61 | KDR | 0.92925695 |
| 62 | GSK3A | 0.91622941 |
| 63 | TBK1 | 0.90739233 |
| 64 | MAP3K6 | 0.89629412 |
| 65 | PDGFRB | 0.89553994 |
| 66 | MAPKAPK5 | 0.89547671 |
| 67 | MAPK13 | 0.88596952 |
| 68 | MAP4K1 | 0.87963365 |
| 69 | MAPK7 | 0.87653409 |
| 70 | JAK2 | 0.86852489 |
| 71 | BUB1 | 0.85807278 |
| 72 | ZAP70 | 0.85277367 |
| 73 | CDC42BPA | 0.83494418 |
| 74 | PDK1 | 0.78045222 |
| 75 | PKN1 | 0.76906415 |
| 76 | LYN | 0.75071852 |
| 77 | ADRBK2 | 0.74564059 |
| 78 | SCYL2 | 0.74020780 |
| 79 | * PRKACG | 0.71699997 |
| 80 | SYK | 0.70925583 |
| 81 | CDK9 | 0.70688398 |
| 82 | * PRKAA1 | 0.70313409 |
| 83 | STK38 | 0.69822777 |
| 84 | PAK2 | 0.68853418 |
| 85 | MTOR | 0.68851462 |
| 86 | MAPK11 | 0.67816665 |
| 87 | PRKD3 | 0.67452561 |
| 88 | PRKD1 | 0.67244967 |
| 89 | PTK2 | 0.66568265 |
| 90 | JAK1 | 0.66438359 |
| 91 | TYRO3 | 0.66378701 |
| 92 | STK38L | 0.65527156 |
| 93 | IRAK4 | 0.64569519 |
| 94 | LCK | 0.63526141 |
| 95 | CDK8 | 0.61730309 |
| 96 | CDK7 | 0.60822876 |
| 97 | PRKG2 | 0.59857432 |
| 98 | YES1 | 0.58275790 |
| 99 | RPS6KB2 | 0.58134158 |
| 100 | RIPK4 | 0.57682611 |
| 101 | MAPKAPK3 | 0.57065678 |
| 102 | EEF2K | 0.56664032 |
| 103 | IGF1R | 0.56184637 |
| 104 | RET | 0.55998821 |
| 105 | JAK3 | 0.54192655 |
| 106 | MAP2K3 | 0.53625380 |
| 107 | KSR2 | 0.53526843 |
| 108 | CLK1 | 0.53262644 |
| 109 | IKBKB | 0.51796570 |
| 110 | MAP3K1 | 0.51290839 |
| 111 | ILK | 0.51272758 |
| 112 | DAPK3 | 0.50600921 |
| 113 | IRAK3 | 0.49610514 |
| 114 | HIPK2 | 0.49469813 |
| 115 | IKBKE | 0.48176550 |
| 116 | MARK1 | 0.47959894 |
| 117 | ICK | 0.46943344 |
| 118 | TAOK3 | 0.46391372 |
| 119 | PINK1 | 0.45609903 |
| 120 | * MAPK3 | 0.45527674 |
| 121 | CDK5 | 0.43189766 |
| 122 | RAF1 | 0.42293020 |
| 123 | TYK2 | 0.41873821 |
| 124 | ABL1 | 0.41629358 |
| 125 | PIM1 | 0.41475987 |
| 126 | MAP2K4 | 0.41229958 |
| 127 | MAP3K11 | 0.40376625 |
| 128 | SRPK1 | 0.39925209 |
| 129 | AKT2 | 0.39791588 |
| 130 | CASK | 0.39656329 |
| 131 | CSK | 0.38722709 |
| 132 | INSR | 0.38260951 |
| 133 | PDK2 | 0.37761326 |
| 134 | TTN | 0.37158612 |
| 135 | * CAMK1 | 0.36487095 |
| 136 | * RPS6KA3 | 0.36281089 |
| 137 | DYRK1B | 0.35702122 |
| 138 | FGFR4 | 0.35238084 |
| 139 | SRC | 0.35010733 |
| 140 | PTK2B | 0.33623436 |
| 141 | BMPR1B | 0.32524774 |
| 142 | FER | 0.31637235 |
| 143 | * PRKG1 | 0.31632470 |
| 144 | HCK | 0.30913095 |
| 145 | MAPK15 | 0.29092209 |
| 146 | CSNK2A2 | 0.29021323 |
| 147 | CCNB1 | 0.27192144 |
| 148 | TXK | 0.27098295 |
| 149 | MARK2 | 0.26107874 |
| 150 | TESK2 | 0.25932155 |
| 151 | TNK2 | 0.25698416 |
| 152 | MAPK12 | 0.25635397 |
| 153 | PAK4 | 0.25256471 |
| 154 | CSNK2A1 | 0.22979900 |
| 155 | LRRK2 | 0.22899446 |
| 156 | CDK4 | 0.22764566 |
| 157 | PRKD2 | 0.21243818 |
| 158 | MYLK | 0.21033178 |
| 159 | MAP3K7 | 0.20405531 |
| 160 | PIK3CG | 0.19842564 |
| 161 | GRK7 | 0.18336081 |
| 162 | CAMKK1 | 0.17586717 |
| 163 | RPS6KA4 | 0.17349696 |
| 164 | ADRBK1 | 0.17030622 |
| 165 | IRAK1 | 0.16821593 |
| 166 | CAMK4 | 0.16126635 |
| 167 | * MAPK4 | 0.16110448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.96512663 |
| 2 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 5.17224675 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 5.04052745 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 4.25642042 |
| 5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.85684335 |
| 6 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 3.66800068 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.64004576 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.55876511 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.38431967 |
| 10 | Thyroid cancer_Homo sapiens_hsa05216 | 3.14538907 |
| 11 | Protein export_Homo sapiens_hsa03060 | 3.10402498 |
| 12 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.92781106 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 2.88722860 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72497101 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.71073852 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.65860670 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 2.50831789 |
| 18 | Homologous recombination_Homo sapiens_hsa03440 | 2.49232003 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.46744439 |
| 20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.41322741 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.37149840 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36841057 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34196675 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 2.31044472 |
| 25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.22191975 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 2.21118939 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.16452875 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.03545052 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.98161465 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94688258 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.80479821 |
| 32 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78149699 |
| 33 | Spliceosome_Homo sapiens_hsa03040 | 1.75499203 |
| 34 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.72249763 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.71494547 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68946144 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.65427725 |
| 38 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.54272621 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51762015 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51582409 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48015512 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.46772830 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44472377 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.40133129 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.39700763 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37405846 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32581118 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.29387538 |
| 49 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.22670650 |
| 50 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.21196237 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.21186907 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.20265984 |
| 53 | Basal transcription factors_Homo sapiens_hsa03022 | 1.15400831 |
| 54 | Proteasome_Homo sapiens_hsa03050 | 1.14512047 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.14292903 |
| 56 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.13765479 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.11858507 |
| 58 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10610868 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10480190 |
| 60 | Renin secretion_Homo sapiens_hsa04924 | 1.10386323 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.10334869 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.09534578 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08449898 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.07684166 |
| 65 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.02830413 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96312748 |
| 67 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94093947 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.92669004 |
| 69 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91929502 |
| 70 | Insulin resistance_Homo sapiens_hsa04931 | 0.87838896 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86619969 |
| 72 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86255513 |
| 73 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80941771 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80325137 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.79007948 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76443198 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74960084 |
| 78 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74931395 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74704641 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74096827 |
| 81 | Cell cycle_Homo sapiens_hsa04110 | 0.73927148 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.73334939 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73036124 |
| 84 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71218818 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70661962 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.68330728 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.67282470 |
| 88 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67002318 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66190318 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64785185 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64691749 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63740042 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62265731 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.59189122 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56928474 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56868858 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56770194 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.55945036 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.55617781 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.55513565 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55257207 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.55100923 |
| 103 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54667238 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53584285 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.52793736 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52737670 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52711912 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52076510 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51649703 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.51231930 |
| 111 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50796135 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50679956 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50185130 |
| 114 | RNA transport_Homo sapiens_hsa03013 | 0.49370108 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48793303 |
| 116 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48601398 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48533815 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45883044 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45772991 |
| 120 | Morphine addiction_Homo sapiens_hsa05032 | 0.43368769 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.42942544 |
| 122 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42921420 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42833524 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40680112 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40450509 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.38925200 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38822385 |
| 128 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37733382 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37726528 |
| 130 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37603071 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.36814295 |
| 132 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33751799 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33639199 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33545273 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33136555 |
| 136 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32837524 |
| 137 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.32818055 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32540611 |
| 139 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31630491 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31397566 |
| 141 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.30033881 |
| 142 | Alcoholism_Homo sapiens_hsa05034 | 0.27633537 |
| 143 | Asthma_Homo sapiens_hsa05310 | 0.27097845 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.26047798 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.25997209 |
| 146 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24655901 |
| 147 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22766764 |
| 148 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.22721070 |
| 149 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22255110 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21203596 |
| 151 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.20514181 |
| 152 | Melanogenesis_Homo sapiens_hsa04916 | 0.19594007 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19321499 |
| 154 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18759238 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.18508311 |
| 156 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18415929 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.18132431 |
| 158 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18130785 |
| 159 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.18037681 |
| 160 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17982098 |
| 161 | Salmonella infection_Homo sapiens_hsa05132 | 0.17364749 |
| 162 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.16877090 |
| 163 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16381043 |
| 164 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.16021099 |
| 165 | Pathways in cancer_Homo sapiens_hsa05200 | 0.15244825 |
| 166 | Circadian rhythm_Homo sapiens_hsa04710 | 0.14545133 |
| 167 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14122515 |
| 168 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14064278 |
| 169 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13971017 |
| 170 | Tuberculosis_Homo sapiens_hsa05152 | 0.13871106 |
| 171 | Legionellosis_Homo sapiens_hsa05134 | 0.13663082 |
| 172 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13196791 |
| 173 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.12808016 |
| 174 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.12509753 |
| 175 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.12454632 |
| 176 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.12260912 |
| 177 | Gap junction_Homo sapiens_hsa04540 | 0.10123380 |
| 178 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09798163 |
| 179 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.09407808 |
| 180 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07908108 |
| 181 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.07407227 |
| 182 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07161150 |
| 183 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.06376166 |
| 184 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.06161499 |
| 185 | Adherens junction_Homo sapiens_hsa04520 | 0.05884850 |

